Home > Neurology > ECTRIMS 2021 > Progressive MS > Charcot Award 2021: Progressive MS, a personal perspective

Charcot Award 2021: Progressive MS, a personal perspective

Presented By
Prof. Alan J. Thompson, University College London, UK
The 2021 Charcot Award was awarded to Prof. Alan J. Thompson (University College London, UK). “The Charcot Award is viewed by the MS community as the ultimate accolade for a lifetime’s work, and I’m absolutely delighted to be the 2021 recipient,” Prof. Thompson said. As part of this honour, Prof. Thompson gave the Charcot Lecture at the ECTRIMS 2021 meeting [1]. “Approximately 1 to 1.5 million people are currently suffering from progressive forms of MS worldwide,” Prof. Thompson started his lecture. “The increasing disability, reduced quality of life, and costs for the individual and the community that are a result of this condition demonstrate the need to focus on progressive MS.” Prof. Thompson argued that most therapies in the last 3 decades were developed for relapsing-remitting MS, leaving progressive MS underexposed. “In primary progressive MS, ocrelizumab is the only effective therapy that has been developed in the last 30 years. Fortunately, in rec...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on